Kabid Humas Polda Metro Jaya Kombes Ade Ary Syam mengatakan, kebakaran terjadi pada Senin (24/2) sekitar pukul 03.00 WIB.

MUMBAI, India, Feb. 20, 2025 /PRNewswire/ -- APAR (BSE: 532259) (NSE: APARINDS) (REUTERS: APAR.NS) (BLOOMBERG: APR:IN) plans to exhibit its comprehensive suite of solutions for the energy sector ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

APAR Industries Limited, a diversified billion-dollar conglomerate with a rich legacy spanning more than 66 years. As they navigate the complexities of the 21st century, APAR is dedicated to ...

It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings report. Even as the pharmaceutical giant exceeded Wall Street estimates ...

Feb 25 (Reuters) - Drugmaker Merck (MRK.N), opens new tab said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government price setting, which would become ...

Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public attention lately after HHS Secretary Robert F. Kennedy Jr.'s links to the ...

Deutsche Bank analyst James Shin downgraded Merck (MRK) to Hold from Buy with a price target of $105, down from $128. The firm believes the “real culprit” for Merck shares remaining under ...

Merck & Co.’s first trial over the safety of its blockbuster Gardasil cancer vaccine was cut short and rescheduled amid concerns that jurors might be influenced by controversy this month around ...

Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...